Achieve Life Sciences
ACHV
66 hedge funds and large institutions have $48.9M invested in Achieve Life Sciences in 2025 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 21 closing their positions.
897% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $239K
2% more funds holding
Funds holding: 65 → 66 (+1)
5% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 21
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
17% less capital invested
Capital invested by funds: $59.3M → $48.9M (-$10.4M)
45.24% less ownership
Funds ownership: 75.65% → 30.41% (-45%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$2.13M |
| 2 |
Pathstone Holdings
Englewood,
New Jersey
|
+$1.38M |
| 3 |
Two Sigma Investments
New York
|
+$1.21M |
| 4 |
Squarepoint
New York
|
+$987K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$856K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$12.2M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$9.13M |
| 3 |
PBM
Propel Bio Management
Los Angeles,
California
|
-$6.5M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.65M |
| 5 |
CC
Clearline Capital
New York
|
-$2.4M |
ACHV Hedge Fund Activity: Q3 2025 in Review
66 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2025, worth a combined $48.9M — down 17% from $59.3M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ACHV positions and 21 closed out — a net gain of 1 holder — while 18 added to existing stakes and 18 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $2.13M. The largest seller was Franklin Resources, cutting an estimated $12.2M.
- 66 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2025, up from 65 in Q2 2025.
- Funds reported $48.9M of Achieve Life Sciences stock for Q3 2025, down 17% quarter-over-quarter.
- 22 funds opened new Achieve Life Sciences positions in Q3 2025 and 21 closed out, a net change of +1 holder.
- The largest Achieve Life Sciences buyer in Q3 2025 was Marshall Wace, an estimated $2.13M added.
- The largest Achieve Life Sciences seller in Q3 2025 was Franklin Resources, an estimated $12.2M sold.
Based on aggregated 13F filings for Q3 2025.